ATE222904T1 - Verfahren zur herstellung des magnesiumsalzes eines substituierten sulphinylheterozyklus - Google Patents

Verfahren zur herstellung des magnesiumsalzes eines substituierten sulphinylheterozyklus

Info

Publication number
ATE222904T1
ATE222904T1 AT97921045T AT97921045T ATE222904T1 AT E222904 T1 ATE222904 T1 AT E222904T1 AT 97921045 T AT97921045 T AT 97921045T AT 97921045 T AT97921045 T AT 97921045T AT E222904 T1 ATE222904 T1 AT E222904T1
Authority
AT
Austria
Prior art keywords
producing
magnesium salt
substituted sulphinyl
heterocycle
sulphinyl heterocycle
Prior art date
Application number
AT97921045T
Other languages
English (en)
Inventor
Jan-Ake Hoegberg
Panagiotis Ioannidis
Anders Mattson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20402358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE222904(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE222904T1 publication Critical patent/ATE222904T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97921045T 1996-04-26 1997-04-22 Verfahren zur herstellung des magnesiumsalzes eines substituierten sulphinylheterozyklus ATE222904T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601598A SE508669C2 (sv) 1996-04-26 1996-04-26 Nytt förfarande
PCT/SE1997/000674 WO1997041114A1 (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle

Publications (1)

Publication Number Publication Date
ATE222904T1 true ATE222904T1 (de) 2002-09-15

Family

ID=20402358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97921045T ATE222904T1 (de) 1996-04-26 1997-04-22 Verfahren zur herstellung des magnesiumsalzes eines substituierten sulphinylheterozyklus

Country Status (40)

Country Link
US (1) US6124464A (de)
EP (1) EP0897386B1 (de)
JP (1) JP4233115B2 (de)
KR (1) KR100468331B1 (de)
CN (1) CN1100776C (de)
AR (1) AR006640A1 (de)
AT (1) ATE222904T1 (de)
BR (1) BR9708829A (de)
CA (1) CA2251636C (de)
CZ (1) CZ295067B6 (de)
DE (1) DE69714987T2 (de)
DK (1) DK0897386T3 (de)
DZ (1) DZ2209A1 (de)
EE (1) EE03485B1 (de)
EG (1) EG23874A (de)
ES (1) ES2180981T3 (de)
HK (1) HK1016978A1 (de)
HR (1) HRP970210B1 (de)
HU (1) HUP9901798A3 (de)
ID (1) ID16685A (de)
IL (1) IL126716A (de)
IS (1) IS1984B (de)
MA (1) MA24143A1 (de)
MY (1) MY119011A (de)
NO (1) NO318850B1 (de)
NZ (1) NZ332154A (de)
PL (1) PL188824B1 (de)
PT (1) PT897386E (de)
RS (1) RS49718B (de)
RU (1) RU2163238C2 (de)
SA (1) SA97170759B1 (de)
SE (1) SE508669C2 (de)
SI (1) SI0897386T1 (de)
SK (1) SK282752B6 (de)
TN (1) TNSN97068A1 (de)
TR (1) TR199802156T2 (de)
TW (1) TW420676B (de)
UA (1) UA51699C2 (de)
WO (1) WO1997041114A1 (de)
ZA (1) ZA973153B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875872B1 (en) * 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
DE19843413C1 (de) 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
NZ511169A (en) * 1998-11-18 2003-06-30 Astrazeneca Ab Process for making substituted sulphinyl heterocycles containing an imidazole moiety
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
JP5412023B2 (ja) * 2000-08-04 2014-02-12 武田薬品工業株式会社 ベンズイミダゾール化合物の塩およびその用途
EP1469839A2 (de) * 2002-01-25 2004-10-27 Santarus, Inc. Transmukosale verabreichung von protonenpumpeninhibitoren
WO2003074514A1 (en) 2002-03-05 2003-09-12 Astrazeneca Ab Alkylammonium salts of omeprazole and esomeprazole
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
BR0315574A (pt) * 2002-10-22 2005-09-20 Ranbaxy Lab Ltd Forma amorfa de esomeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação
WO2004046134A2 (en) * 2002-11-18 2004-06-03 Dr. Reddy's Laboratories Limited Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation
JP2006514108A (ja) * 2002-12-19 2006-04-27 テバ ファーマシューティカル インダストリーズ リミティド パントプラゾールナトリウムの固体状態、それらの調製方法、及び公知のパントプラゾールナトリウム水和物の調製方法
EP1606279A1 (de) * 2003-02-28 2005-12-21 Ranbaxy Laboratories, Ltd. Polymorphe von s-omeprazol
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE0302382D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
ITMI20031813A1 (it) * 2003-09-23 2005-03-24 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procedimento per la preparazione di pantoprazolo e suoi sali.
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2246149B1 (es) 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
US20060141054A1 (en) * 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
US8779175B2 (en) * 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
EP1801110A1 (de) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Argininsalz des Esomeprazols
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US20080139623A1 (en) 2006-06-12 2008-06-12 Lilach Hedvati Amorphous and crystalline forms of pantoprazole magnesium salt
EP1947099A1 (de) * 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Verfahren zur Entfernung von Lösungsmitteln in Omeprazol-Salzen
AU2008217603C1 (en) 2007-02-21 2013-08-15 Cipla Limited Process for the preparation of esomeprazole magnesium dihydrate
US8106210B2 (en) * 2007-10-08 2012-01-31 Hetero Drugs Limited Polymorphs of esomeprazole salts
EP2147918A1 (de) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Verfahren zur Herstellung von S-Omeprazol-Magnesium in einer stabilen Form
WO2010097583A1 (en) 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
US20110207779A1 (en) * 2010-02-25 2011-08-25 Glenmark Generics Ltd Process for the preparation of esomeprazole magnesium
EP2426111A1 (de) 2010-08-09 2012-03-07 Laboratorios Del. Dr. Esteve, S.A. Feste 4-[-2-[[5-Methyl-1-(2-naphthalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholinhydrochlorid-Formen
CN103467453A (zh) * 2013-09-13 2013-12-25 上海海虹实业(集团)巢湖今辰药业有限公司 一种奥美拉唑镁原料药制备方法
CN106397399A (zh) * 2015-07-29 2017-02-15 陕西合成药业股份有限公司 一种泮托拉唑镁的精制方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
FI861772A (fi) * 1985-05-07 1986-11-08 Chemie Linz Ag Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
FI864138A (fi) * 1985-10-16 1987-04-17 Fisons Plc Heterocykliska blandningar.
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
US5817338A (en) * 1994-07-08 1998-10-06 Astra Aktiebolag Multiple unit tableted dosage form of omeprazole

Also Published As

Publication number Publication date
MA24143A1 (fr) 1997-12-31
NO984903L (no) 1998-10-21
KR20000065018A (ko) 2000-11-06
ID16685A (id) 1997-10-30
UA51699C2 (uk) 2002-12-16
JP4233115B2 (ja) 2009-03-04
DK0897386T3 (da) 2002-10-28
HK1016978A1 (en) 1999-11-12
IS4872A (is) 1998-10-19
EP0897386A1 (de) 1999-02-24
US6124464A (en) 2000-09-26
EE03485B1 (et) 2001-08-15
RS49718B (sr) 2007-12-31
CZ295067B6 (cs) 2005-05-18
YU44898A (sh) 1999-07-28
TNSN97068A1 (fr) 1999-12-31
PL188824B1 (pl) 2005-04-29
CN1216989A (zh) 1999-05-19
KR100468331B1 (ko) 2005-03-16
CZ339898A3 (cs) 1999-03-17
HRP970210B1 (en) 2002-06-30
TW420676B (en) 2001-02-01
RU2163238C2 (ru) 2001-02-20
PL329683A1 (en) 1999-04-12
HRP970210A2 (en) 1998-04-30
SA97170759B1 (ar) 2006-09-25
HUP9901798A2 (hu) 2000-04-28
IL126716A (en) 2003-10-31
WO1997041114A1 (en) 1997-11-06
AU711345B2 (en) 1999-10-14
AU2719397A (en) 1997-11-19
TR199802156T2 (xx) 1999-02-22
SE9601598L (sv) 1997-10-27
DE69714987T2 (de) 2003-04-30
CA2251636C (en) 2001-04-10
MY119011A (en) 2005-03-31
SE508669C2 (sv) 1998-10-26
SE9601598D0 (sv) 1996-04-26
ES2180981T3 (es) 2003-02-16
HUP9901798A3 (en) 2003-02-28
BR9708829A (pt) 1999-08-03
NO318850B1 (no) 2005-05-18
AR006640A1 (es) 1999-09-08
EP0897386B1 (de) 2002-08-28
NZ332154A (en) 2002-03-01
PT897386E (pt) 2002-12-31
DE69714987D1 (de) 2002-10-02
EE9800363A (et) 1999-04-15
IL126716A0 (en) 1999-08-17
IS1984B (is) 2005-02-15
SK282752B6 (sk) 2002-12-03
JP2000509067A (ja) 2000-07-18
DZ2209A1 (fr) 2002-12-03
SI0897386T1 (en) 2002-12-31
ZA973153B (en) 1997-10-27
EG23874A (en) 2007-11-27
NO984903D0 (no) 1998-10-21
SK140798A3 (en) 1999-04-13
CA2251636A1 (en) 1997-11-06
CN1100776C (zh) 2003-02-05

Similar Documents

Publication Publication Date Title
ATE222904T1 (de) Verfahren zur herstellung des magnesiumsalzes eines substituierten sulphinylheterozyklus
DE19782019T1 (de) Verfahren zur Herstellung eines Lithiumsalzes
DE69713215T2 (de) Verfahren zur Herstellung eines sauren wässrigen Aluminiumoxidsoles
DE59510034D1 (de) Verfahren zur herstellung dekorativer mehrschichtlackierungen
ATE182150T1 (de) Verfahren zur herstellung sildenafil
DE60004649D1 (de) Verfahren zur herstellung nicht-hygroscopische l (-) - carnitine salze
DE69817881D1 (de) Verfahren zur herstellung eines laminats
DE69734843D1 (de) Verfahren zur Herstellung eines gegossenen Artikels
DE950125T1 (de) Verfahren zur herstellung eines diamantbeschichteten gegenstandes
DE69429233D1 (de) Verfahren zur Herstellung eines Feingussmodells
DE69602481D1 (de) Verfahren zur flexiblen Herstellung unterschiedlicher Motorblöcke
DE69707924D1 (de) Verfahren zur herstellung von magnesium
DE69707566T2 (de) Verfahren zur Herstellung eines Formkörpers
DE69710898D1 (de) Verfahren zur herstellung achsensymmetrischer teile
ATE297379T1 (de) Verfahren zur herstellung eines geschützten 4- aminomethyl-pyrrolidin-3-ons
DE69917657T2 (de) Verfahren zur herstellung von carbonsäuren
DE59807658D1 (de) Verfahren zur herstellung mehrschichtiger überzüge
ATE202358T1 (de) Verfahren zur herstellung eines clavulansäuresalzes
DE69701915T2 (de) Verfahren zur Herstellung eines einbügelbaren Einlagestoffs
ATE207900T1 (de) Verfahren zur herstellung von ropivacainehydrochlorid-monohydrat
ATE307817T1 (de) Verfahren zur herstellung von cefpodoxim-proxetil diastereoisomeren
DE69822977D1 (de) Verfahren zur Herstellung eines Formkörpers
DE69941017D1 (de) Verfahren zur Herstellung eines Thermokopfes
DE60128842D1 (de) Verfahren zur Herstellung eines Kühleinsatzes
DE59605878D1 (de) Verfahren zur Herstellung eines kristallinen Magnesiumhydroxids

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification